Specialty Pharmacy

Top news of the day from across the health care landscape.

Gene mapping tools identify a rare disease caused by ASXL2 gene mutation, which shares similarities to other rare genetic disorders.

Dietary deficiencies may contribute to inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.

Tumor markers can help guide future treatments for patients with bladder cancer.

Top news of the week in oncology and cancer drug development.

A cell-editing platform allowed researchers to find genetic mutations that allow human immune cells to be resistant to HIV.

Top news of the day from across the health care landscape.

Newly-discovered compound blocks an essential protein in sustaining tumor growth.

Variants identify areas of the genome associated with multiple sclerosis.

Orencia is the only CTLA-4lg approved in the United States, European Union, and Japan for the treatment of rheumatoid arthritis.

Risk of AMD reduced by more than one-third in individuals who closely follow a Mediterranean diet rich in fruit.

Compounded drugs accounted for more than half of cost increases under Medicare Part D in the last year.

Descovy showed non-inferiority to Truvada, and benefited bone and kidney health.

Keytruda approved as a first-line treatment for non-small cell lung cancer.

Swedish study suggests that more American men can opt surveillance over prostate cancer treatment.

Paul LeVine, vice president of Analytic Services at TrialCard, discusses how specialty pharmacies can best support patients on a specialty drug therapy.

Although any amount of exercise is beneficial, exceeding the recommended level produces the most benefits for diabetes patients.

Top news of the day from across the health care landscape.

Xgeva targets the RANK ligand pathways to prevent the creation, function, and survival of osteoclasts.

Ibalizumab achieves primary endpoint in decreasing the viral load of patients with drug-resistant HIV.

Novel PCSK9 inhibitor bococizumab halted after manufacturer determines limited value.

New findings reveal 2 subsets of the disease which may have an effect on how the disease responds to standard therapy.

Ibalizumab caused 83% of HIV-positive patients to achieve a virologic response.

A specific mark in histones speeds up repairs in cancer cells, increasing their resistance to treatment.

Top news of the day from across the health care landscape.

A novel approach looks to provide researchers with the tools to make accurate and safe predictions for cancer patients.

Premiums in employer plans are growing more slowly on average, as are individual income levels.